The subject of the order is the successive supply of biological medicines for Dolnośląski Centrum Rehabilitacji Sp. z o. o. in Kamienna Góra.
A detailed assortment list of ordered medicines and their estimated quantities are set out in Part II of the ToR.
Medicines must have a marketing authorization in accordance with the Act of 6.9.2001 - Pharmaceutical Law (i.e. Journal of Laws of 2017, item 2211) and be on the "Official List of Medicinal Products Authorized for Marketing on the territory of Polish Republic."
Rituximab.Rituximab violet. 500 mg - 50 ml - 50 pcs.
Golimumab.Golimumab 50 mg / 0.5 ml solution to shake - 1 shock - 80 pcs.
Tocilizumab 200 mg / 10 ml amp.Tocilizumab 200 mg / 10 ml amp - 200 pcs.
Tocilizumab 400 mg / 20 ml amp.Tocilizumab 400 mg / 20 ml amp - 300 pcs.
Tocilizumab 80 mg / 4 ml amp.Tocilizumab 80 mg / 4 ml amp - 600 pcs.
Adalimumab.Adalimumab 40 mg * 2 amp-syringe - 300 op.
Infliximab.Infliximab 100 mg vial. - 39 pcs.
Etanercept 25 mg / 0.5 ml.Etanercept 25 mg / 0.5 ml * 4 amp-shock - 30 pack.
Etanercept 50 mg.Etanercept 50 mg * 4 amp-shock - 280 op.
Certolizumab.Certolizumab 200 mg / ml * 2 amp-shot - 120 op.